abstract |
Provided herein are methods, drug formulations, and dosing regimens for improving cognitive function in a normal or cognitively impaired subject. For instance, methods provided herein comprise administering a GABA A receptor antagonist so that peak concentration of the GABA A receptor antagonist occurs when the subject is asleep. |